CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 127 enrolled
Drug / intervention
Cholecalciferol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01736865
NCT01736865Phase 3Completed
CompareCT.gov

Vitamin D for Established Type 2 Diabetes (DDM2)

Tufts Medical Center·interventional·Posted Nov 29, 2012·Updated Apr 1, 2020

In Brief

A Phase 3 clinical trial evaluating Cholecalciferol and Placebo for Type 2 Diabetes. Completed, enrolled 127 participants across 2 sites.

Detailed Summary

This research study in adults with established type 2 diabetes will test whether daily vitamin D supplementation affects how the body processes glucose (sugar).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 29, 2012
Enrollment StartDec 1, 2012
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 13.6 years ago

Interventions

Cholecalciferoldrug

Placebodrug